CANNABIS, STRATEGIES
Rob Hill, CPA
Chief Financial Officer,
Emerald Health Therapeutics Inc.
Follow
About Rob
Rob Hill brings more than 20 years of accounting, finance, and senior leadership experience to Emerald as a seasoned manager of private and publicly traded technology and financial services businesses in Canada, USA, and Asia. Prior to joining Emerald, he was the chief financial officer of Tokyo-based Minkabu, a technology company advancing sophisticated stock market intelligence and financial data solutions. Before that, Mr. Hill held financial leadership positions at Haywood Securities in Vancouver, Vignette Corp. and Trilogy Software in Austin, Texas. He earned a Bachelor of science from the University of British Columbia and his certification from the Chartered Professional Accountants of British Columbia, Canada while articling with KPMG LLP.
Rob's Videos
Emerald Health Therapeutics is a health Canada licensed producer of cannabis for medical and recreational use with decades of experience in pharmaceutical innovation. Hear from CFO, Rob Hill, on how Emerald is uniquely positioning itself in the global cannabis space by delivering competitive differentiation in the sourcing & cultivation of low-cost quality cannabis and using scientific research to develop novel products.
Canada has been at the center of the cannabis expansion, which is taking place on a global scale. The opening of the recreational cannabis market has created significant opportunities for companies. This panel features leading Canadian cannabis companies and this is a discussion that investors need to attend.
Emerald Health Therapeutics is positioning itself to be one of the leading producers and product innovators in the growing global medicinal market and the Canadian legal recreational market, launching on October 17, 2018.